Catalog Number : 500-P212
Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hCTGFL/WISP-2. Anti-Human CTGFL/WISP-2 specific antibody was purified by affinity chromatography employing immobilized hCTGFL/WISP-2 matrix.
|Application:||ELISA, Western Blot, Immunohistochemistry|
Anti-Human CTGFL/WISP-2 (BioGems Catalog #120-16)
This antibody stained formalin-fixed, paraffin-embedded sections of human breast invasive ductal carcinoma. The recommended concentration is 0.5 µg/mL with an overnight incubation at 4°C. An HRP-labeled polymer detection system was used with a DAB chromogen. Heat induced antigen retrieval with a pH 6.0 sodium citrate buffer is recommended. Additional protein blocks were used in conjunction with the secondary reagents. Optimal concentrations and conditions may vary.
To detect hCTGFL/WISP-2 by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with BioGems' Biotinylated Anti-Human CTGFL/WISP-2 (60-108BT) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hCTGFL/WISP-2.
To detect hCTGFL/WISP-2 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hCTGFL/WISP-2 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.